메뉴 건너뛰기




Volumn 19, Issue 6, 2000, Pages 463-471

Removal of amphipathic epitopes from genetically engineered antibodies: Production of modified immunoglobulins with reduced immunogenicity

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITOPE; IMMUNOGLOBULIN; PEPTIDE; R3 ANTIBODY; UNCLASSIFIED DRUG;

EID: 0034532441     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/027245700750053959     Document Type: Article
Times cited : (38)

References (34)
  • 1
    • 0016756272 scopus 로고
    • Continuous cultures of fused cells secreting antibody of predefined specificity
    • (1975) Nature , vol.256 , pp. 495-497
    • Koehler, G.1    Milstein, C.2
  • 14
    • 0025848797 scopus 로고
    • A possible procedure for reducing the immunogenicity of antibody varaible domains while preserving their ligand-binding properties
    • (1991) Mol Immunol , vol.28 , pp. 489-498
    • Padlan, E.A.1
  • 31
    • 0031014086 scopus 로고    scopus 로고
    • Human Fab fragments specific for the Haemophilus influenzae polysaccharide isolated from a bacteriophage combinatorial library use variable region gene combinations and express an idiotype that mirrors in vivo expression
    • (1997) Infect Immun , vol.65 , pp. 261-266
    • Reason, D.C.1    Wagner, T.C.2    Lucas, A.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.